Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients-Reference-Cited by-同舟云学术

Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients

Published:2024-07 Issue:7 Volume:30 Page:692.e1-692.e12
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Kernan Nancy A.^ORCID,Klein Elizabeth^ORCID,Mauguen Audrey^ORCID,Torok-Castanza Joanne,Prockop Susan E.^ORCID,Scaradavou Andromachi,Curran Kevin,Spitzer Barbara^ORCID,Cancio Maria,Ruggiero Julianne,Allen Jennifer,Harris Andrew^ORCID,Oved Joseph,O'Reilly Richard J.,Boelens Jaap Jan^ORCID

Funder

Memorial Sloan-Kettering Cancer Center

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Reference26 articles.

1. Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study;Peters;J Clin Oncol,2021

2. Hematopoietic cell transplantation in the treatment of pediatric acute myelogenous leukemia and myelodysplastic syndromes: guidelines from the American Society of Transplantation and Cellular Therapy;Tarlock;Transplant Cell Ther,2022

3. More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling;Bader;Blood Adv,2019

4. Outcomes of measurable residual disease in pediatric acute myeloid leukemia before and after hematopoietic stem cell transplant: validation of difference from normal flow cytometry with chimerism studies and wilms tumor 1 gene expression;Jacobsohn;Biol Blood Marrow Transplant,2018

5. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group;Bader;J Clin Oncol,2009